RE:QuestionCamphikefish wrote: Question for all the wise and experienced pharma and biotech investors who have much more insight than I do . I looked back at the original statement from Theralase pointing out Tld-1433 killed 99.99 % of the type 2 Covid strain and had yet to be tested against the type 3 strain we are exposed to at this time . Perhaps there is a new variant which makes this an irrelavant point however , if Tld-1433 is successful at destroying the type 3 virus at the same rate , does big pharma ( and the market ) have an appetite for such an effective treatment ? Given the profits yet to be realized from booster after booster , will there be an effort to possibly capture and bury this technology due to its possible overwhelming efficacy against COVID-19 ? Perhaps it is a silly question and if so , so be it . Like others , I continue to be completely confused as to why this technology / company has not gained share price momentum . If it's half as good as lab results suggest in vitro against cancers and viruses how on earth are we still floundering at such low levels ? Hence the genesis of my question . Does the profit driven mindset of big pharma and other influencers have a desire and a need for such a wonder compound which could potentially be a one and done treatment ? This keeps me awake at night even after all these years ! I'm puzzled . Seems like we should be above $5.00 by now easily but I must be missing something obviously .